LUHFT paves the way in sarcoma research

After recruiting more than 200 patients and families, LUHFT has joined the largest genetic sarcoma study in the world whose outcomes have generated the first genetic map of sarcomas.

The map identifies certain genes that, when inherited, can cause sarcoma. Crucially, the findings will allow earlier detection and potentially improve survival rates for patients. The increased understanding of risk will also help to manage underlying factors as well as make more personalised decisions about treatments.

Mr CR Chandrasekar, a consultant on the orthopaedic surgery team thanked the patients and their families who joined the study, explaining that their participation was ‘essential’ to the results received. He adds that it will 'pave the way for further research and understanding of sarcomas.'

Another win for team LUHFT!